EurekAlert! -
9 Apr 2020 06:00
(Children's Hospital of Philadelphia) Researchers at Children's Hospital of Philadelphia (CHOP) have pinpointed a genetic variation responsible for driving the development of inflammatory bowel disease (IBD). The genetic pathway associated with this variation is involved in other immune disorders, suggesting the mechanism they identified could serve as an important therapeutic target.
Share this Article
Comment on this Article
Please to comment